Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolidics
Singapore, Singapore
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
Biolidics has commercialized the ClearCell FX1 System and CTChip FR1 biochip, which enable label-free enrichment of circulating tumor cells (CTCs) from blood for cancer diagnostics; products are in use in routine clinical and laboratory settings across Asia, and some laboratory-developed tests (LDTs) are in collaboration with healthcare and research institutions in China[1][2].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- DeviceDiagnostic
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Sysmex Corporation (joint development and commercialization of CTC assays)IncelDx (distribution partnership for bioINK PD-L1 CTC core kit integration with ClearCell FX1)Agen Medicine Laboratory Technology Company (LDTs in China)TopGene Medical Laboratory Company (China)Genecast Biotechnology (China)Hangzhou Normal University (China, cancer biomarker validation)
Beyond the preview
Go deeper on Biolidics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biolidics.